Delivery Order SPE2DB22D1106-SPE2DB25FFCN1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dobutamine 250 mg/250 mL in D5W solution with a ceiling value of $1,517.43. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,471.62 for Dobutamine 500 mg/250 mL D5W 250 mL, a critical cardiac medication used in military and federal healthcare settings. The award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dobutamine 500 mg/250 mL in 5% dextrose solution with a ceiling value of $1,748.21. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2024, for the supply of Dobutamine 500 mg/250 mL in D5W solution, with a contract value of $1,239.62 and ultimate completion date of November 5, 2024. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,658.91 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes a firm fixed price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This non-set-aside, competitively awarded contract is valued at $2,881.19 with a firm fixed price structure and an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563152800 - DOBUTAMINE 250 MG/250 ML-D5W 250ML pharmaceutical products. The order has a potential value of $1,294.40 and a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a prime contractor that has previously received multiple federal contract awards from DLA to supply pharmaceuticals, medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of 4564027880 - DOBUTAMINE 500 MG/250 ML D5W 250ML, a pharmaceutical product, at a firm fixed price of $1,254.14. The order has a performance period through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and the award is not associated with any...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,286.17 delivery order contract is for the supply of DOBUTAMINE 500 MG/250 ML D5W 250ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,227.01, is for the delivery of 4567731933 DOBUTAMINE 500 MG/250 ML D5W 250ML medical supplies. The contract has a firm fixed price pricing type and a period of performance through March 31, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCN1Delivery Order
The Defense Logistics Agency awarded a $2,094.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 1,000 mg/250 ml in D5W solution. This delivery order, issued on August 10, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive award for pharmaceutical medical supplies. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, ranging from small-value transactions to substantial orders. This delivery order for Dobutamine, a cardiac inotropic agent used in medical emergencies and critical care settings, exemplifies the company's role in supplying specialized pharmaceutical products essential to military medical operations and readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/10/25 |